Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Australia’s Groundbreaking Stem Cell Sciences Closed By New U.S. Owner

This article was originally published in PharmAsia News

Executive Summary

Stem Cell Sciences, Australia's first stem-cell biotech, is going out of business, the result of a decision by its new U.S. owner. StemCells of California acquired the intellectual property of SCS for handling embryonic stem cells and other technology along with patents on 20 sets of products. The closing of SCS leaves Australia with only Mesoblast, since Bresagen ended its stem-cell work and Embryonic Stemcells relocated to Singapore. The California company bought SCS in March for $4 million. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts